<DOC>
	<DOC>NCT02971930</DOC>
	<brief_summary>This study is to generate qualitative data to evaluate the impact of frequency of FVIII infusions on patients' satisfaction with treatment and their quality of life.</brief_summary>
	<brief_title>Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patient is enrolled in the BAY949027 extension studies or is within 3 months of having completed participation in the BAY949027 extension studies; Patient allocated to Arm 2, Arm 3 or Arm 4 of BAY949027 extension studies. Arm 2 Prophylaxis treatment of BAY949027; 2 infusions per week during the extension study Arm 3 Prophylaxis treatment of BAY949027; infusion every 5 days during the extension study Arm 4 Prophylaxis treatment of BAY949027; every 7 days during the extension study Evidence of a personally signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study; Patient must be willing and able to participate in a telephone interview lasting up to 30 minutes; Patient must have sufficient cognitive and linguistic capacities to allow them to actively participate in an interview lasting 30 minutes. Patient is part of Arm 1: Ondemand treatment of BAY949027 at individual dose and number of infusions based upon location and severity of bleeds; Patient is unlikely to comply with the study protocol (e.g. uncooperative attitude) or unlikely to complete the study for any reason in the opinion of the recruiter; Patient has great difficulty hearing or reading; Patient has any significant comorbid condition (including uncontrolled psychiatric conditions) that might limit or interfere with their ability to talk about their Hemophilia A and participate in the study; Patient has severe neurological or cognitive deficits that might affect their ability to participate in an interview.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>